|
|
||||||||
|
FIGURE 4. Percentage of segments in each patient with SUVmax PCa > SUVmax of benign histopathology (class width, 20%) vs. number of patients in respective class (2 patients are not listed because they had PCa in all segments).
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |